Societal barriers to chemoprevention

Bookmark and Share
Published: 4 Aug 2016
Views: 1817
Dr Andrea De Censi - E.O. Ospedali Galliera, Genova, Italy

Dr Censi speaks with ecancertv at the 2016 BACR and ECMC Joint Meeting about the hurdles facing adoption of chemopreventative strategies.

He highlights the lack of monetary and emotional investment in prevention compared to diagnosis and treatment of cancers, and the uncertainty surrounding clinical data due to the lengthy timeline of studies.

Dr Cesni also considers the regulatory issues of off-brand prescription and repurposing of drugs, compared to the widespread public acceptance of food supplements, and the incorporation of preventative behaviours into screening and counselling.